S-Bank Fund Management’s Eli Lilly LLY Stock Holding History

S-Bank Fund Management’s Portfolio LLY Stock Details LLY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$18.9M	Sell	20,538 -9,317	-31%	-$9.45M	2.81%	6
2025 Q4	$32.1M	Buy	29,855 +2,077	+7%	+$1.99M	4.16%	5
2025 Q3	$21.2M	Buy	27,778 +7,846	+39%	+$5.84M	2.81%	6
2025 Q2	$15.5M	Buy	19,932 +10,527	+112%	+$8.18M	2.29%	7
2025 Q1	$7.77M	Buy	+9,405	New	+$7.83M	1.46%	15

Other funds holding LLY

Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

PNC Financial Services Group Pittsburgh, Pennsylvania $173B AUM 20.72% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

S-Bank Fund Management's LLY Position: Q1 2026 in Review

S-Bank Fund Management reduced its Eli Lilly (LLY) stake by 31% in Q1 2026, selling an estimated $9.45M and leaving 20,538 shares worth $18.9M. The position accounts for 2.81% of the portfolio, ranked #6.

S-Bank Fund Management first reported a position in LLY in Q1 2025 and has held it in 5 quarters since. The position peaked at $32.1M in Q4 2025. 4,355 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

S-Bank Fund Management held 20,538 shares of Eli Lilly worth $18.9M as of Q1 2026.
S-Bank Fund Management sold 9,317 Eli Lilly shares in Q1 2026, an estimated $9.45M.
Eli Lilly made up 2.81% of S-Bank Fund Management's portfolio in Q1 2026, its #6 holding.
S-Bank Fund Management first reported a position in Eli Lilly in Q1 2025 and has held it in 5 quarters since.
S-Bank Fund Management's Eli Lilly position peaked at $32.1M in Q4 2025.
4,355 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on S-Bank Fund Management's 13F filing for Q1 2026, filed 11 May 2026.